- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
DOJ Clears Cigna–Express Scripts Merger
The approval comes 6 months after the 2 companies fist made an announcement of the proposed merger.
It's official: Cigna can acquire the largest pharmacy benefits manager (PBM) in the United States, Express Scripts, for a whopping $67 billion after receiving clearance from the Antitrust Division of the United States Department of Justice (DOJ).
“We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company,” said David Cordani, president and CEO of Cigna, in a statement.
The announcement of the merger was first made back in March 2018, with plans for $48.75 billion in cash exchange and the remaining amount as stock. A majority (90%) of Cigna’s shareholders approved of the deal in an August vote.
“Together, we believe we will be able to do even more to reduce healthcare costs, expand choice, and improve patient outcomes,” said Tim Wentworth, president and CEO of Express Scripts, reacting to the approval. “Today’s decision is one more important milestone in our effort to combine two innovative health services leaders into a company that will transform health care.”
Till date, the 2 companies have worked with insurance regulators in 16 states and plan to continue working with officials in other states to gain clearance for the merger.
Cordani will head the combined company and Wentworth will remain president of the PBM.
The deal is expected to close toward the end of 2018.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
